Kansas pharmacists held a day of advocacy at the states capitol in Topeka to push for restrictions on pharmacy benefit managers that they say are driving independent pharmacies out of business by paying them below cost
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
Gastrointestinal symptoms such as nausea, which are among the most common side effects, generally improve within weeks after the final dose, though individual experiences vary
And there's a variety of different SNPs that show people
55% decrease in snacking episodes in the Supresa group Appetite Control : By the end of the study,